Xadago

Xadago

CVS logo
CVS
$1,146.06
Albertsons logo
Albertsons
$1,106.57
Walmart logo
Walmart
Pay Online$1,165.15
Walgreens logo
Walgreens
$1,175.88
Show this card to your pharmacist

Xadago Savings card

$1,106.57

BIN
015995
ID
LHKXM458406
PCN
GDC
GRP
DR33

Print or send this coupon to your phone

About Xadago

Drug Details

Safinamide, marketed under the brand name Xadago, is prescribed to manage symptoms of Parkinson's disease in combination with levodopa/carbidopa medications. This drug is particularly effective in reducing "off" periods, which are times when symptoms such as shakiness, stiffness, and difficulty moving are more pronounced. As a monoamine oxidase type B (MAO-B) inhibitor, safinamide enhances dopamine levels in the brain by preventing the breakdown of this crucial neurotransmitter. By doing so, it helps alleviate the motor symptoms associated with Parkinson's disease. It's typically taken orally once a day. Common side effects can include uncontrolled muscle movements. Always consult with a healthcare professional before starting any new medication.

Price history for Xadago

30 Tablets, 100MG

Average retail price for Xadago

Average SaveHealth price for Xadago

Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.

*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.

Related Prescriptions

Xadago dosage forms

DosageQuantityPrice fromPer unit
50MG30 Tablets$1,110.77$37.03
100MG30 Tablets$1,109.97$37.00

Xadago FAQs

Xadago is used as an adjunctive treatment for patients with Parkinson's disease who are experiencing "off" episodes while on a stable dose of levodopa/carbidopa. It helps to improve motor function and manage symptoms during these periods.

Yes, Xadago (safinamide) is a selective monoamine oxidase B (MAO-B) inhibitor. It is used as an adjunctive treatment for patients with Parkinson's disease.

Coverage for Xadago (safinamide) under Medicare can vary depending on the specific Medicare plan. Generally, Medicare Part D or Medicare Advantage plans with prescription drug coverage may cover Xadago, but it is important to check the formulary of the specific plan. Patients should contact their plan provider directly to confirm coverage details and any associated costs.

Yes, Xadago (safinamide) is approved by the FDA. It was approved in March 2017 for use as an add-on treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing "off" episodes.

The cost of Xadago can vary depending on factors such as the pharmacy, location, insurance coverage, and dosage. It is recommended to check with local pharmacies or consult with a healthcare provider or insurance company for the most accurate and up-to-date pricing information.

Read All FAQs